Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Assets Average (2018 - 2021)

Historic Assets Average for Cogent Biosciences (COGT) over the last 4 years, with Q3 2021 value amounting to $222.0 million.

  • Cogent Biosciences' Assets Average rose 15970.51% to $222.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $222.0 million, marking a year-over-year increase of 15970.51%. This contributed to the annual value of $150.2 million for FY2020, which is 12189.8% up from last year.
  • Latest data reveals that Cogent Biosciences reported Assets Average of $222.0 million as of Q3 2021, which was up 15970.51% from $233.1 million recorded in Q2 2021.
  • Over the past 5 years, Cogent Biosciences' Assets Average peaked at $244.3 million during Q1 2021, and registered a low of $35.0 million during Q2 2020.
  • Moreover, its 4-year median value for Assets Average was $83.6 million (2019), whereas its average is $109.6 million.
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 5351.95% in 2020, then skyrocketed by 56595.14% in 2021.
  • Over the past 4 years, Cogent Biosciences' Assets Average (Quarter) stood at $90.4 million in 2018, then crashed by 40.62% to $53.7 million in 2019, then soared by 264.18% to $195.4 million in 2020, then increased by 13.59% to $222.0 million in 2021.
  • Its last three reported values are $222.0 million in Q3 2021, $233.1 million for Q2 2021, and $244.3 million during Q1 2021.